How Peptides Are Made: From Lab Synthesis to Finished Product

Understanding how peptides are manufactured explains a lot about the market: why purity varies between suppliers, why certain peptides cost more, why longer sequences are harder to produce, and how to interpret a certificate of analysis.

Solid-Phase Peptide Synthesis (SPPS)

Nearly all synthetic peptides are made using solid-phase peptide synthesis, a method developed by Robert Bruce Merrifield in 1963 (Nobel Prize, 1984). The basic principle: anchor the first amino acid to an insoluble resin bead, then add amino acids one at a time in the correct sequence.

The Fmoc cycle

Modern SPPS uses Fmoc (fluorenylmethyloxycarbonyl) chemistry. Each amino acid addition follows a four-step cycle:

Step 1: Deprotection. Remove the Fmoc protecting group from the last amino acid on the chain using piperidine. This exposes the free amine, ready for the next coupling.

Step 2: Coupling. Activate the incoming amino acid's carboxyl group (using activating agents like HBTU or HATU) and react it with the free amine on the resin-bound chain. A new peptide bond forms.

Step 3: Washing. Wash away excess reagents and byproducts with solvent (typically DMF or DCM). This is why solid-phase synthesis works — the growing peptide is anchored to the bead, so everything else washes away.

Step 4: Capping (optional). Acetylate any unreacted amines to prevent them from coupling in future cycles, which would create deletion sequences (peptides missing one amino acid).

This cycle repeats for each amino acid in the sequence. A 15-residue peptide like BPC-157 requires 15 complete coupling cycles.

Yield and sequence length

Each coupling step has a yield of ~99–99.5% under optimal conditions. This sounds excellent until you multiply across a full sequence:

• 10-mer: 99.5%¹⁰ = 95.1% theoretical yield
• 20-mer: 99.5%²⁰ = 90.5%
• 40-mer: 99.5%⁴⁰ = 81.8%
• 60-mer: 99.5%⁶⁰ = 74.1%

This is why longer peptides are exponentially harder to produce at high purity. Each coupling that falls below 99.5% compounds the problem. This also explains why pharmaceutical peptides like semaglutide (31 residues with modifications) are expensive — maintaining high coupling efficiency across many cycles requires precise conditions.

Cleavage and side-chain deprotection

After the full sequence is assembled, two things happen simultaneously:

1. Cleavage from the resin — the peptide is released from the solid support
2. Side-chain deprotection — protecting groups on amino acid side chains (which prevent unwanted reactions during synthesis) are removed

This is typically done with trifluoroacetic acid (TFA) cocktails containing scavengers (water, triisopropylsilane, ethanedithiol) that trap reactive cations released during deprotection.

The crude peptide — now free in solution — contains the target sequence plus accumulated impurities: deletion sequences, truncated sequences, deprotection byproducts, and resin fragments.

Purification

Preparative HPLC

The crude peptide is purified using reversed-phase high-performance liquid chromatography (RP-HPLC). The peptide mixture is loaded onto a C18 column and eluted with a gradient of acetonitrile in water (with TFA as ion-pairing agent). Different peptide species elute at different retention times based on hydrophobicity.

The target peak is collected and the fractions on either side (containing closely related impurities) are discarded. This is the primary determinant of final purity:

• > 98% purity — tight fraction collection, more material discarded, higher cost. Required for pharmaceutical products.
• 95–98% — good research grade. Adequate for most applications.
• > 90% — acceptable for some research purposes but contains significant impurities.
• < 90% — not suitable for biological applications.

Other purification methods

• Ion-exchange chromatography — separates by charge, useful for peptides with different net charges
• Size-exclusion chromatography — separates by molecular weight, removes aggregates
• Affinity chromatography — for peptides with specific binding tags

Quality testing

Analytical HPLC

A small sample of the purified peptide is analyzed on an analytical HPLC column. The chromatogram shows peaks for the target peptide and any remaining impurities. Purity is calculated as the area percentage of the target peak.

Mass spectrometry

Electrospray ionization mass spectrometry (ESI-MS) or MALDI-TOF confirms the molecular weight matches the expected value. This verifies correct sequence assembly and identifies modifications or truncations.

Amino acid analysis (AAA)

The peptide is hydrolyzed and the individual amino acids are quantified. This confirms the correct amino acid composition and provides accurate concentration data.

Endotoxin testing

For injectable peptides, bacterial endotoxin (LAL) testing is essential. Endotoxin contamination from gram-negative bacteria during manufacturing can cause fever, inflammation, and in severe cases, septic shock.

Research-grade vs. pharmaceutical-grade

The distinction matters:

Parameter	Research-grade	Pharmaceutical-grade
Purity (HPLC)	> 95% typical	> 98–99%
Endotoxin testing	Sometimes	Always (USP <85>)
Sterility testing	Rarely	Always (USP <71>)
cGMP manufacturing	No	Yes
Regulatory oversight	None	FDA/EMA
Batch documentation	CoA (basic)	Full batch records
Cost	$$	$$$$

Most peptides available from research suppliers are research-grade. The pharmaceutical-grade equivalents (semaglutide as Ozempic, tesamorelin as Egrifta) go through full cGMP manufacturing with extensive quality controls — which is a major reason for their dramatically higher cost.

Why purity matters

Impurities in research peptides fall into several categories:

• Deletion peptides — missing one or more amino acids; may have partial or no activity
• Truncated sequences — incomplete synthesis; inactive
• Oxidized forms — Met(O), Trp(O) variants; may have reduced activity
• TFA/acetate salts — counterions from synthesis; affect weight-based dosing (a "10 mg" vial at 95% purity with TFA content may contain only ~8 mg of active peptide)
• Endotoxin — bacterial contaminant; causes inflammatory responses

For research peptides, requesting and reading the Certificate of Analysis (CoA) — including HPLC chromatogram and MS data — is the minimum due diligence. If a supplier can't provide these, the product quality is unknown.